Replies to post #177531 on Biotech Values

[DewDiligence]

NYT cover story on payers’ machinations to reduce US drug prices:

http://www.nytimes.com/2014/06/21/business/health-plans-bring-pressure-to-bear-on-drug-prices.html

There’s nothing here that we haven’t discussed on this board (e.g. the erosion of US Advair sales in #msg-101502988). The article mentions the HCV market in passing, but the NYT author (Andrew Pollack) misinterprets Rick Gonzalez’s comments from ABBV’s 1Q14 CC (just as happened contemporaneously—see #msg-101124948).